PET Imaging for neurodegenerative diseases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
230
NCT06254469
Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 1, 2025
Completion: Jun 30, 2029
Loading map...